$RIBT NIA Announces New Plant-Based Protein Play!

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
109
$RIBT NIA Announces New Plant-Based Protein Play!

dawsons creek find, TY

Their last 2 picks>>>

https://stockcharts.com/h-sc/ui?s=LWAY&p=...9767287955

https://stockcharts.com/h-sc/ui?s=FIOGF&p...2163666902

Story>>>>>

NIA is excited to announce its #3 favorite overall stock suggestion... Ricebran Technologies (RIBT), currently trading on the NASDAQ for $2.90 per share. RIBT is NIA's latest plant-based protein play!

Beyond Meat (BYND) CEO Ethan Brown was recently quoted as saying, “Pea protein is an amazing resource for us, it works well, but there’s nothing particularly special about it. If you think about the plant kingdom, there are so many other stocks we can use — mung bean, brown rice, mustard seed, lentils. We will have a much more diverse bench of proteins.”

RIBT has developed technology for extracting protein from rice for use in meat products. Click here to see for yourself!

RIBT's ricebran protein products for meat are free of GMOs, soy, and gluten just like the pea protein used by BYND and NIA's #2 favorite overall stock suggestion: Lifeway Foods (LWAY). BYND went public in a May 2nd IPO at an initial price of $25 per share and quickly rose to a June 18th all-time high of $201.88 per share for a gain of 707.52% from its IPO price in only six weeks.

On May 24th, NIA announced Burcon Nutrascience (TSX: BU) as its #1 pea protein play at $0.80 per share and it quickly made a gain of 146.25% to a high of $1.97 per share in only three trading days! BU last week closed on an oversubscribed rights offering raising $15,429,121. Including the rights offering, which allowed BU shareholders to purchase an additional share at $0.35 for each share owned, the adjusted cost per share for NIA members who entered on May 24th at $0.80 per share and still hold their shares is now down to $0.575 per share.

On June 7th, NIA announced Lifeway Foods (LWAY) at $2.10 per share as its new pea protein stock suggestion. On June 17th with LWAY already up 20% to $2.52 per share, NIA released Part 1 of its Top 5 Stock Suggestions report, ranking LWAY #2 with a near perfect confidence rating of 95. Over the following three days, LWAY gained an additional 88.49% to a high of $4.75 per share. At LWAY's June 20th high of $4.75 per share, the stock had gained by 126.19% from NIA's initial suggestion in less than two weeks!

Incredibly, over the last six weeks, NIA was the first and only organization in the world to successfully discover and suggest what became the two biggest pea protein plays in the entire market! BU and LWAY achieved an average gain of 136.22% in an average of 7 trading days!

We are giving RIBT a very high confidence rating of 90 out of 100 and strongly believe it will become the market's next MAJOR plant-based protein play! Tonight we will be discussing how RIBT's largest shareholder is the major investor behind Impossible Foods, the latest plant-based meat unicorn that will have its IPO later this year and will likely be worth countless BILLIONS!

We are nearly 100% sure that LWAY will reach new 52-week highs in the near-future! We will be releasing a major LWAY update later this week comparing its extremely low valuation to the latest implied valuation of new plant-based dairy start-up Ripple (a private company)!

The only stock that NIA ranked higher than LWAY in Part 1 of its Top 5 Stock Suggestions report was Fiore Gold (TSXV: F) at a price of $0.375 per share with a perfect confidence rating of 100. Fiore Gold (TSXV: F) gained by 30.67% over the following seven trading days to a June 25th high of $0.49 per share on total volume of 1.54 MILLION shares or 2.53X its trailing twelve month average seven day trading volume of 607,819 shares. At its June 25th high of $0.49 per share, Fiore Gold had gained by 113.04% since NIA initially announced the company as its #1 stock suggestion for 2019 on November 22nd at $0.23 per share.

Amazingly, NIA's #1 stock suggestion for the previous year of 2018, QIWI Plc (QIWI) hit a new two-year high last week of $20.90 per share for a gain of 49.5% from NIA's December 28, 2017 suggestion price of $13.98 per share. Keep in mind, December 2017 is when Bitcoin hit its record high of $20,000 and everybody was demanding that we announce a blockchain stock as our #1 pick for 2018. When NIA announced QIWI on December 28th, its average daily volume for the previous three weeks was only 276,653 shares. Following NIA's December 28th announcement, QIWI immediately gained by $1.24 or 8.87% to $15.22 per share on volume of 2,212,000 shares or 8X its average daily volume! The next day after NIA released its in-depth QIWI report, it gained another $2.11 or 13.86% to $17.33 per share on volume of 4,914,100 shares or 17.76X its average daily volume! On the following trading day, QIWI gained another $0.97 or 5.6% to a high of $18.30 per share on volume of 2,683,400 shares or 9.7X its average daily volume!

In just the first three trading days, QIWI gained by $4.32 or 30.9% to a high of $18.30 per share on total three-day volume of 9,809,500 shares, which was 11.82X QIWI's average three-day volume of 829,960 shares! QIWI's total dollar volume exceeded $160 MILLION in three days! NIA had simultaneously suggested QIWI $15 February 2018 call options at $1 as its #1 option suggestion for 2018 and they reached a January 23, 2018 high of $3.80 for a gain of 280% in less than one month!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

CRMLS Partners with Rayse to Enhance Agent-Client Transparency

Updated Category News Views 108

CRMLS Enhances Agent Value with Rayse Platform California Regional MLS (CRMLS), the leading multiple listing service in the nation, has made a significant move by integrating Rayse, a state-of-the-art agent value platform, into its offerings. This collaboration allows all CRMLS agent users to access Rayse at no cost directly through their MLS dashboard, marking a pivotal...

Continue Reading
UMG & TikTok's New Deal: A Boon for Artists?

Updated Category News Views 8

A New Era for Music Collaboration Universal Music Group and TikTok just cranked up the volume on their alliance, announcing a fresh, multi-year licensing agreement. This ain't just another handshake—it signals a seismic shift in how music gets discovered and consumed globally. Strengthened Bonds and Broadened Horizons Under this new agreement, TikTok will offer its...

Continue Reading
How an Investment in Thermo Fisher Scientific Transforms Wealth

Updated Category News Views 425

Unveiling the Growth of Thermo Fisher Scientific Investing is often seen as a pathway to wealth, and for those who placed their trust in Thermo Fisher Scientific Inc. (NYSE: TMO) two decades ago, the rewards have been substantial. This company, which specializes in scientific instrumentation, reagents, and consumables, has consistently outperformed the market. 20 Years of...

Continue Reading
European Energy A/S Launches Tender Offer for Green Bonds

Updated Category News Views 63

European Energy A/S Announces Its Tender Offer European Energy A/S has officially informed the market about a new opportunity for its bondholders. The company is targeting holders of its existing senior unsecured green bonds due in 2025 and 2026, inviting them to tender their bonds as part of a strategic financing move. Tender Offer Details Under this tender offer, which...

Continue Reading
Building a Rehabilitation Hospital: Encompass and BSA Join Forces

Updated Category News Views 170

Encompass Health and BSA Health System Join Forces Encompass Health Corp. and BSA Health System have embarked on a collaborative journey that aims to enhance rehabilitation services for patients recovering from various health challenges. This partnership marks a significant expansion in the healthcare landscape, focusing on providing dedicated rehabilitation care. A...

Continue Reading